tiprankstipranks
Advertisement
Advertisement

HK:2480 Stock Latest News

Beijing Luzhu Biotechnology Sets Board Meeting to Review Interim Results
Company AnnouncementsBeijing Luzhu Biotechnology Sets Board Meeting to Review Interim Results
6d ago
2480
Luzhu Biotech’s Herpes Zoster Vaccine LZ901 Shows Strong Phase III Results in China
PremiumCompany Announcements
Luzhu Biotech’s Herpes Zoster Vaccine LZ901 Shows Strong Phase III Results in China
10d ago
2480
Beijing Luzhu Biotechnology Consolidates Company Secretary and Governance Roles
PremiumCompany Announcements
Beijing Luzhu Biotechnology Consolidates Company Secretary and Governance Roles
2M ago
2480
Beijing Luzhu Calls 2026 AGM and Seeks Fresh Share Issuance Mandate
PremiumCompany Announcements
Beijing Luzhu Calls 2026 AGM and Seeks Fresh Share Issuance Mandate
3M ago
2480
Beijing Luzhu Reallocates IPO Proceeds to Core Vaccine Programs and Working Capital
PremiumCompany Announcements
Beijing Luzhu Reallocates IPO Proceeds to Core Vaccine Programs and Working Capital
4M ago
2480
Luzhu Biotech Narrows 2025 Loss as Core Herpes Zoster Vaccine Nears Key Milestones
PremiumCompany AnnouncementsLuzhu Biotech Narrows 2025 Loss as Core Herpes Zoster Vaccine Nears Key Milestones
5M ago
2480
Beijing Luzhu Biotechnology Revamps Key Company Secretarial and Governance Roles
Premium
Company Announcements
Beijing Luzhu Biotechnology Revamps Key Company Secretarial and Governance Roles
5M ago
2480
Beijing Luzhu Biotechnology Sets March Board Meeting to Approve 2025 Results
Premium
Company Announcements
Beijing Luzhu Biotechnology Sets March Board Meeting to Approve 2025 Results
6M ago
2480
Beijing Luzhu Biotechnology Successfully Completes Phase I Trial of LZ901 in U.S.
PremiumCompany Announcements
Beijing Luzhu Biotechnology Successfully Completes Phase I Trial of LZ901 in U.S.
10M ago
2480
Beijing Luzhu Biotechnology Announces Board Composition
PremiumCompany Announcements
Beijing Luzhu Biotechnology Announces Board Composition
11M ago
2480
Beijing Luzhu Biotechnology Reports Reduced Losses and Milestones in H1 2025
PremiumCompany Announcements
Beijing Luzhu Biotechnology Reports Reduced Losses and Milestones in H1 2025
12M ago
2480
Beijing Luzhu Biotech Announces Positive Trial Results for LZ901 Vaccine
PremiumCompany Announcements
Beijing Luzhu Biotech Announces Positive Trial Results for LZ901 Vaccine
1y ago
2480
Beijing Luzhu Biotechnology Schedules Board Meeting for Interim Results
PremiumCompany AnnouncementsBeijing Luzhu Biotechnology Schedules Board Meeting for Interim Results
1y ago
2480
Beijing Luzhu Biotechnology Appoints New Lead Independent Director
Premium
Company Announcements
Beijing Luzhu Biotechnology Appoints New Lead Independent Director
1y ago
2480
Beijing Luzhu Biotechnology Enhances Nomination Committee’s Role
Premium
Company Announcements
Beijing Luzhu Biotechnology Enhances Nomination Committee’s Role
1y ago
2480
Beijing Luzhu Biotechnology Announces Board of Directors and Roles
PremiumCompany Announcements
Beijing Luzhu Biotechnology Announces Board of Directors and Roles
1y ago
2480
Beijing Luzhu Biotechnology Holds Successful AGM with Key Resolutions Passed
PremiumCompany Announcements
Beijing Luzhu Biotechnology Holds Successful AGM with Key Resolutions Passed
1y ago
2480
Beijing Luzhu Biotechnology Announces 2025 AGM with Key Resolutions
PremiumCompany Announcements
Beijing Luzhu Biotechnology Announces 2025 AGM with Key Resolutions
1y ago
2480
Beijing Luzhu Biotechnology Announces Board and Governance Changes
PremiumCompany Announcements
Beijing Luzhu Biotechnology Announces Board and Governance Changes
1y ago
2480
Beijing Luzhu Biotechnology Reports 2024 Annual Results and Advances in R&D
PremiumCompany AnnouncementsBeijing Luzhu Biotechnology Reports 2024 Annual Results and Advances in R&D
1y ago
2480
Luzhu Biotechnology’s Herpes Zoster Vaccine Application Accepted by NMPA
Premium
Company Announcements
Luzhu Biotechnology’s Herpes Zoster Vaccine Application Accepted by NMPA
2y ago
2480
Beijing Luzhu Biotech Secures RMB570M for Growth
Premium
Company Announcements
Beijing Luzhu Biotech Secures RMB570M for Growth
2y ago
2480

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >